Advanced Glycation End Products in Hemodialyzed Patients with Diabetes Mellitus Correlate with Leptin and Leptin/Body Fat Ratio

References

• Vlassara H. Recent progress in advanced glycation end products and diabetic complications. Diabetes 1997; 46(Suppl. 2)S19–S25
   Google Scholar
• Miyata T., van Ypersele de Strihou C., Kurokawa K., Baynes J.W. Alterations in nonenzymatic biochemistry in uremia: origin and significance of “carbonyl stress” in long-term uremic complications. Kidney Int. 1999; 55(2)389–399
   Google Scholar
• Raj D.S.C., Choudhury D., Welbourne T.C., Levi M. Advanced glycation end products: a nephrologists perspective. Am. J. Kidney Dis. 2000; 35(3)365–380
   Google Scholar
• Maillard L.C. Action des acides amines sur les sucres; formacion des Melaniodines par voie methodique. CR Acad. Sci. 1912; 154: 66–68
   Google Scholar
• Baynes J.W., Thorpe S.R. Role of oxidative stress in diabetic complications. a new perspective on an old paradigm. Diabetes 1999; 48(1)1–9
   Google Scholar
• Koschinsky T., He C.J., Mitsuhashi T., Bucala R., Liu C., Buenting C., Heitmann K., Vlassara H. Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc. Natl. Acad. Sci. USA 1997; 94(12)6474–6479
   Google Scholar
• Bierhaus A., Hofmann M.A., Ziegler R., Nawroth P.P. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The age concept. Cardiovasc. Res. 1998; 37(3)586–600
   Google Scholar
• Kislinger T., Fu C., Huber B., Qu W., Taguchi A., Yan S.D., Hofmann M., Yan S.F., Pischensrieder M., Stern D., Schmidt A.M. Nε-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signalling pathways and modulate gene expression. J. Biol. Chem. 1999; 274(44)31740–31749
   Google Scholar
• Chappey O., Dosquet C., Wautier M.P., Wautier J.L. Advanced glycation end products, oxidant stress, and vascular lesions. Eur. J. Clin. Invest. 1997; 27(2)97–108
   Google Scholar
• Miyata T., Kurokawa K., van Ypersele de Strihou C. Advanced glycation and lipooxidation end products: role of reactive carbonyl compounds generated during carbohydrate and lipid metabolism. J. Am. Soc. Nephrol. 2000; 11(9)1744–1752
   Google Scholar
• Nakayama M., Kawaguchi Y., Yamada K., Hasegawa T., Takozoe K., Katoh N., Hayakawa H., Osaka N., Yamamoto H., Ogawa A., Kubo H., Shigematsu T., Sakai O., Horiuchi S. Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int. 1997; 51(1)182–186
   Google Scholar
• Henle T., Deppisch R., Beck W., Hergesell O., Hansch G.M., Ritz E. Advanced glycated end-products (AGE) during haemodialysis treatment: discrepant results with different methodologies reflecting the heterogenity of AGE compounds. Nephrol. Dial. Transplant 1999; 14(8)1968–1975
   Google Scholar
• Allen T.H., Peng M.T., Chen K.P. Prediction of total adiposity from skinfold and the curvilinear relationship between external and internal adiposity. Metabolism 1956; 5: 346–352
   Google Scholar
• Munch G., Kies R., Wessel A., Riederer P., Bahner U., Heidland A., Niwa T., Lemke H.D., Schinzel R. Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA. Eur. J. Clin. Chem. Clin. Biochem. 1997; 35(9)669–677
   Google Scholar
• Papanastasiou P., Grass L., Rodela H., Patrikarea A., Oreopoulos D., Diamandis E.P. Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPD. Kidney Int. 1994; 46(1)216–222
   Google Scholar
• Dolhofer-Bliesener R., Lechner B., Deppisch R., Ritz E., Gerbitz K.D. Immunological determination of advanced glycosylation end-products in human blood and urine. Nephrol. Dial. Transplant 1995; 10(5)657–664
   Google Scholar
• Miyata T., Ueda Y., Schinzato T., Yoshiyasu I., Tanaka S., Kurokawa K., van Ypersele de Strihou C., Maeda K. Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: renal implications in the pathophysiology of pentosidine. J. Am. Soc. Nephrol. 1996; 7(8)1198–1206
   Google Scholar
• Makita Z., Bucala R., Rayfield E.J., Friedman E.A., Kaufman A.M., Korbet S.M., Barth R.H., Winston J.A., Fuh H., Manogue K.R., Cerami A., Vlassara H. Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure. Lancet 1994; 343(8912)1519–1522
   Google Scholar
• Vlassara H. Serum advanced glycosylation end products: a new class of uremic toxins?. Blood Purif. 1994; 12(1)54–59
   Google Scholar
• Stein G., Franke S., Mahiout A., Schneider S., Sperschneider H., Borst S., Vienken J. Influence of dialysis modalities on serum AGE levels in end-stage renal disease patients. Nephrol. Dial. Transplant 2001; 16(5)999–1008
   Google Scholar
• Haluzík M., Marková M., Sulková S., Haluzíková D., Svobodová J., Bednářová V., Jiskra J. Relation between serum levels of leptin, blood cell count, and erythropoietin levels in hemodialysed patients. Cas. Lek. Ces. 2000; 139(23)731–734
   Google Scholar
• Sharma K., Considine R.V., Michael B., Dunn S.R., Weisberg L.S., Kurnik B.R., Kurnik P.B., O'Connor J., Sinha M., Caro J.F. Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Int. 1997; 51(6)1980–1985
   Google Scholar
• Grunfeld C., Zhao C., Fuller J., Pollack A., Moser A., Friedman J., Feingold K.R. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hammsters. J. Clin. Invest. 1996; 97(9)2152–2157
   Google Scholar
• Schmidt A.M., Hori O., Cao R., Yan S.D., Brett J., Wautier J.L., Ogawa S., Kuwabara K., Matsumoto M., Stern D. RAGE: a novel cellular receptor for advanced glycation end products. Diabetes 1996; 45(Suppl. 3)S77–S80
   Google Scholar
• Yan S.D., Stern D., Schmidt A.M. What's the RAGE? The receptor for advanced glycation end products (RAGE) and the dark side of glucose. Eur. J. Clin. Invest. 1997; 27(3)179–181
   Google Scholar
• Kato A., Odamaki M., Maruyama Y., Hishida A. Association between circulating leptin and soluble receptors for tumor necrosis factor-alpha in hemodialysis patients. Clin. Nephrol. 2001; 56(5)370–377
   Google Scholar
• Don B.R., Rosales L.M., Levine N.W., Mitch W., Kaysen G.A. Leptin is a negative acute phase protein in chronic hemodialysis patients. Kidney Int. 2001; 59(3)1114–1120
   Google Scholar
• Stenwinkel P. Leptin and blood pressure—Is there a link?. Nephrol. Dial. Transplant 2000; 15(8)1115–1117
   Google Scholar
• Wu L., Juuilink B.H. Increased methylglyoxal and oxidative stress in hypertensive rat vascular smooth muscle cells. Hypertension 2002; 39(3)809–814
   Google Scholar